Literature DB >> 6734696

Pharmacokinetics of cimetidine in critically ill patients.

R L Nation, K F Ilett, R Tjokrosetio, T E Oh, P Cameron, W Thompson.   

Abstract

Cimetidine disposition was studied after rapid (1 min) intravenous infusion in eight critically ill patients aged between 20 years and 77 years; one patient was studied on two occasions. Cimetidine dose was 300 mg in seven patients and 400 mg in the remaining patient. Arterial plasma cimetidine concentrations at the end of the infusion were very high and ranged from approximately 15-35 mg/l. Pharmacokinetic parameters displayed wide interpatient variability (coefficients of variation of 30-50%) and significant relationships emerged between some of these parameters and certain patient characteristics. Most notable, total systemic plasma clearance of cimetidine was directly related to estimated creatinine clearance (p less than 0.01). This relationship might prove to be a useful method of individualizing cimetidine dosage in critically ill patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6734696     DOI: 10.1007/BF00548765

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  21 in total

1.  Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1976-10

2.  Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man.

Authors:  W L Burland; W A Duncan; T Hesselbo; J G Mills; P C Sharpe; S J Haggie; J H Wyllie
Journal:  Br J Clin Pharmacol       Date:  1975-12       Impact factor: 4.335

3.  Hypotension after intravenous cimetidine.

Authors:  W A Mahon; M Kolton
Journal:  Lancet       Date:  1978-04-15       Impact factor: 79.321

4.  Pharmacokinetics and bioavailability of cimetidine in gastric and duodenal ulcer patients.

Authors:  A Somogyi; H G Rohner; R Gugler
Journal:  Clin Pharmacokinet       Date:  1980 Jan-Feb       Impact factor: 6.447

5.  Haemodynamic responses to intravenous cimetidine in subjects with normal lung function and in subjects with chronic airway obstruction.

Authors:  P K Lee; C L Lai; A S Lok; T F Tse; K N Lai; S F Chow; K C Lam
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

6.  Blood level of cimetidine in relation to age.

Authors:  A Redolfi; E Borgogelli; E Lodola
Journal:  Eur J Clin Pharmacol       Date:  1979-05-21       Impact factor: 2.953

7.  Cimetidine affords protection equal to antacids in prevention of stress ulceration following thermal injury.

Authors:  H P McElwee; K R Sirinek; B A Levine
Journal:  Surgery       Date:  1979-10       Impact factor: 3.982

8.  Relationship between cimetidine plasma levels and gastric acidity in acutely ill patients.

Authors:  I A Cohen; J K Siepler; R Nation; C T Bombeck; L M Nyhus
Journal:  Am J Hosp Pharm       Date:  1980-03

9.  Cimetidine vs antacid in prophylaxis for stress ulceration.

Authors:  J A Weigelt; C M Aurbakken; B L Gewertz; W H Snyder
Journal:  Arch Surg       Date:  1981-05

10.  Cimetidine plasma concentration-response relationships.

Authors:  R Gugler; G Fuchs; M Dieckmann; A A Somogyi
Journal:  Clin Pharmacol Ther       Date:  1981-06       Impact factor: 6.875

View more
  2 in total

Review 1.  Pharmacokinetics and pharmacodynamics in critically ill patients.

Authors:  H J Mann; D W Fuhs; F B Cerra
Journal:  World J Surg       Date:  1987-04       Impact factor: 3.352

Review 2.  Pharmacokinetics of drugs used in critically ill adults.

Authors:  B M Power; A M Forbes; P V van Heerden; K F Ilett
Journal:  Clin Pharmacokinet       Date:  1998-01       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.